Pathogenic signature of invasive non-typhoidal Salmonella in Africa: implications for vaccine development.

Human Vaccines & Immunotherapeutics
Giulia Piccini, Emanuele Montomoli

Abstract

Invasive non-typhoidal Salmonella (iNTS) infections are a leading cause of bacteremia in Sub-Saharan Africa (sSA), thereby representing a major public health threat. Salmonella Typhimurium clade ST313 and Salmonella Enteriditis lineages associated with Western and Central/Eastern Africa are among the iNTS serovars which are of the greatest concern due to their case-fatality rate, especially in children and in the immunocompromised population. Identification of pathogen-associated features and host susceptibility factors that increase the risk for invasive non-typhoidal salmonellosis would be instrumental for the design of targeted prevention strategies, which are urgently needed given the increasing spread of multidrug-resistant iNTS in Africa. This review summarizes current knowledge of bacterial traits and host immune responses associated with iNTS infections in sSA, then discusses how this knowledge can guide vaccine development while providing a summary of vaccine candidates in preclinical and early clinical development.

References

Jan 1, 1990·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·J R HumbertJ B Schmitz
Mar 1, 1993·Immunology Today·M Clerici, G M Shearer
Oct 1, 1993·Infection and Immunity·A Muotiala, P H Mäkelä
Jan 7, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·S J McSorleyM K Jenkins
Apr 19, 2000·Journal of Leukocyte Biology·H W Mittrücker, S H Kaufmann
Dec 12, 2001·Clinical and Experimental Immunology·O NájeraR Ortiz
Mar 26, 2002·Immunity·Eric A Hughes, Jorge E Galán
Apr 20, 2002·Journal of Pediatric Gastroenterology and Nutrition·Edgar Vásquez-GaribayBarbara Vizmanos-Lamotte
May 1, 1965·The Journal of Pediatrics·J B ROBBINS, H A PEARSON
Dec 23, 2003·Infection and Immunity·Cédric CheminayMichael Hensel
May 13, 2004·Clinical and Diagnostic Laboratory Immunology·Oralia NájeraRocío Ortiz
Oct 23, 2004·The Journal of Infectious Diseases·Calman MacLennanDinakantha S Kumararatne
Nov 9, 2004·Current Opinion in Genetics & Development·Nancy A Moran, Gordon R Plague
Feb 1, 2005·Basic & Clinical Pharmacology & Toxicology·Tom C MartinsenHelge L Waldum
Jun 10, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lisa A CummingsBrad T Cookson
Jan 31, 2006·Proceedings of the National Academy of Sciences of the United States of America·Sébastien P FaucherFrance Daigle
Mar 17, 2007·Clinical and Experimental Immunology·O NájeraR Ortiz
Dec 19, 2007·PLoS Pathogens·Rebecca N NixCorrella S Detweiler
May 1, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Melita A GordonMalcolm E Molyneux
Jun 3, 2009·Proceedings of the National Academy of Sciences of the United States of America·Cristina Gil-CruzAdam F Cunningham
Jun 23, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tom A BarrDavid Gray
Oct 13, 2009·The Cochrane Database of Systematic Reviews·Friday OdeyAngela Oyo-Ita
Dec 17, 2009·The Journal of Allergy and Clinical Immunology·UNKNOWN International Union of Immunological Societies Expert Committee on Primary ImmunodeficienciesJosiah Wedgwood

❮ Previous
Next ❯

Citations

Dec 23, 2020·Nature Microbiology·Caisey V PulfordJay C D Hinton

❮ Previous
Next ❯

Methods Mentioned

BETA
acetylation
glycosylation

Clinical Trials Mentioned

NCT03981952

Software Mentioned

sSA
CVD

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.